Eli Lilly raises its full-year guidance as revenue from its blockbuster weight loss and diabetes drugs beat analysts’ estimates in the third quarter https://t.co/MdyjurUDYZ ...

Market Analysis by covering: Eli Lilly and Company, Pfizer Inc, Novo Nordisk A/S, Metsera Inc. Read 's Market Analysis on Investing.com ...

The struggles of Novo Nordisk has economists wondering whether Denmark's economy relies too heavily on the success of the company -- and its blockbuster weight loss drugs https://t.co/oobJqrCUvI ...